Correlation between DNA alterations and p53 and p16 protein expression in cancer cell lines

Pathology Research and Practice

Volumn 201, Issue 2, 2005, Pages 109-115

  Murai, Yoshihiro ^a   Hayashi, Shinichi ^a   Takahashi, Hiroyuki ^a   Tsuneyama, Koichi ^a   Takano, Yasuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Methylation; Mutation; P16; P53

Indexed keywords

ALPHA TUBULIN; DNA; PROLINE; PROTEIN P16; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ALLELE; ARTICLE; CANCER CELL CULTURE; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; EXON; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; HUMAN CELL; MISSENSE MUTATION; NONSENSE MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE;

EID: 15944365214     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prp.2005.01.002     Document Type: Article

References (20)

1. G. Casey M.E. Lopez J.C. Ramos S.J. Plummer M.J. Arboleda M. Shaughnessy B. Karlan D.J. Slamon DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies Oncogene 13 1996 1971-1981
2. C.C. Harris M. Hollostein Clinical implications of the p53 tumor-suppressor gene N. Engl. J. Med. 329 1993 1318-1327
3. A. Hartmann H. Blaszyk R.M. McGovern J.J. Achroeder J. Cunningham E.M. De Vries J.S. Kovach S.S. Sommer P53 gene mutations inside and outside of exons 5-8: The patterns differ in breast and other cancers Oncogene 10 1995 681-688
4. J.G. Herman J.R. Graff S. Myöhänen B.D. Nelkin S.B. Baylin Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands Proc. Natl. Acad. Sci. 93 1996 9821-9826
5. G.H. Kang S. Lee W.H. Kim H.W. Lee J.C. Kim M.G. Rhyu J.Y. Ro Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma Am. J. Pathol. 160 2002 787-794
6. A.J. Levine P53, the cellular gatekeeper for growth and division Cell 88 1997 323-331
7. J. Lukas D. Parry L. Aagaard D.J. Mann J. Bartkova M. Strauss G. Peters J. Bartek Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 Nature 375 1995 503-506
8. C.G. Maki P.M. Howley Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation Mol. Cell Biol. 17 1997 355-363
9. W. Maltzman L. Czyzyk UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells Mol. Cell Biol. 4 1984 1689-1694
10. Y. Nagata T. Anan T. Yoshida T. Mizukami Y. Taya T. Fujiwara H. Kato H. Saya M. Nakao The stabilization mechanism of mutant-type p53 by impaired ubiquitination: The loss of wild-type p53 function and the hsp90 association Oncogene 18 1999 6037-6049
11. C. Prives P.A. Hall The p53 pathway J. Pathol. 187 1999 112-126
12. M. Raus G. Peters The p16INK4a/CDKN2A tumor suppressor and its relatives Biochim. Biophys. Acta 1378 1998 F115-F177
13. S.C. Righetti G.D. Torre S. Pilotti S. Ménard F. Ottone M.I. Colnaghi M.A. Pierotti C. Lavarino M. Cornarotti S. Oriana S. Böhm G.L. Bresciani G. Spatti F. Zunino A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma Cancer Res. 56 1996 689-693
14. R. Schneider-Stock A. Giers C. Motsch C. Boltze M. Evert B. Freigang A. Roessner Hereditary p16-Leiden mutation in a patient with multiple head and neck tumors Am. J. Hum. Genet. 72 2003 216-218
15. R. Schneider-Stock C. Mawrin C. Motsch C. Boltze B. Peters R. Hartig P. Buhtz A. Giers A. Rohrbeck B. Freigang A. Roessner Retention of the arginine allele in codon 72 of the p53 gene correlation with poor apoptosis in head and neck cancer Am. J. Pathol. 164 2004 1233-1241
16. M. Serrano G.J. Hannon D. Beach A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Nature 366 1993 704-707
17. J. Silva J.M. Silva G. Dominguez J.M. Garcia B. Cantos R. Rodriguez F.J. Larrondo M. Provencio P. Espana F. Bonilla Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms J. Pathol. 199 2003 289-297
18. Y. Tomizawa T. Kohno T. Fujita M. Kiyama R. Saito M. Noguchi Y. Matsuno S. Hirohashi N. Yamaguchi T. Nakajima J. Yokota Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma Oncogene 18 1999 1007-1014
19. K.T. Yeh J.G. Chang T.H. Lin Y.F. Wang N. Tien J.Y. Chang J.C. Chen M.C. Shih Epigenetic changes of tumor suppressor genes, p15, p16, VHL and p53 in oral cancer Oncol. Rep. 10 2003 659-663
20. G.H. Zhao T.C. Li L.H. Shi Y.B. Xia L.M. Lu W.B. Huang H.L. Sun Y. Shen Relationship between inactivation of p16 gene and gastric carcinoma World J, Gastroenterol, 9 2003 905-909